For the Culture By The Culture. ISSN: 3064-9331.
Kentucky’s Hospital Cannabis Problem exposes the gap between medical cannabis approval and bedside access. Kentucky now recognizes terminal illness in its program. However, hospitals, hospices, nursing homes, and other care settings may still decide whether patients can use cannabis where pain, fear, and end-of-life care are happening.
Reefer Report Card Vol. 31 examines a week where cannabis reform quietly retreated. Ballot rollbacks gained traction, federal action stalled, and patients remained unprotected. Legal weed stayed popular, but oversight weakened and accountability slipped. Another week where legalization survived while governance failed
Reefer Report Card Vol. 30 tracks a week where legalization stalled while rollback efforts gained ground. Ballot initiatives threatened regulated markets, federal reform stayed stalled, and patients were left navigating uncertainty. Demand remained strong, but oversight weakened. Another week where cannabis survived while governance quietly failed.
Reefer Report Card Vol. 29 tracks a week where cannabis demand held steady while governance cracked. Ballot initiatives threatened regulated markets, federal reform stalled behind messaging, and patients absorbed the fallout. Legal weed stayed popular. Oversight became optional. Another week where legalization survived but accountability did not.
This week’s Reefer Report Card cuts through the hype around cannabis “rescheduling,” exposing how a label change left federal prohibition fully intact. Arrest authority, workplace punishment, and immigration penalties remain untouched. Headlines claimed progress. Reality delivered none. A week defined by performance over policy, and reform that never arrived.
Hospitals increasingly diagnose Cannabinoid Hyperemesis Syndrome without testing the cannabis products involved. This investigation examines how cartridges, edibles, and other cannabis materials are excluded from medical evaluation, despite known contamination risks, leaving patients with diagnoses based on symptoms and self reported use rather than verified evidence.